Therefore, increasing levels of serum sTLR4, by blocking the binding of TLR4 ligands to membrane-bound TLR4, may inhibit intracellular signaling through membrane-bound TLR4 and then dampen the pro-inflammatory tumor microenvironment. This evidence concerns the gene TLR4 and neoplasm.